Marina A | Drug Development | Clinical Life Science Awards

Prof. Marina A | Drug Development | Clinical Life Science Award

Prof. Marina A | Annamalai University | India

Dr. Marina A., Pharm.D., Ph.D., has established a strong academic and research profile with significant contributions in clinical pharmacy and pharmacology, particularly focusing on polycystic ovary syndrome (PCOS) through randomized controlled trials and high-quality publications. She has authored 1 Scopus-indexed publications, including both research and review articles published in reputed Q1 and Q2 journals such as Inflammopharmacology (IF 5.3), Current Medical Research & Opinion (IF 2.3), European Journal of Obstetrics & Gynecology (IF 2.1), and BMC Nephrology (IF 2.4). Her research has already attracted citations, with her citation count exceeding 120, and she has accumulated a total of 4 Scopus documents, reflecting her growing visibility in the scientific community. Her h-index is 5, which demonstrates not only productivity but also impactful research that is being referenced by peers globally. Alongside publishing, Dr. Marina also serves as a reviewer for respected journals like Reproductive Sciences and Inflammopharmacology, further highlighting her academic credibility. With expertise in regulatory medical writing, teaching, and clinical trial management, she has built a balanced profile bridging academia, industry, and clinical research. Her continuous scholarly output, growing citation base, and expanding peer review roles position her as a promising researcher with strong future potential in life sciences.

Profiles: Scopus | Orcid | LinkedIn

Featured Publications

Marina, A. (in press). Exploring the role of pentoxifylline as a renal protector in diabetic kidney disease: A comprehensive review. BMC Nephrology. Springer Nature. (Q2, IF 2.4, CiteScore 4.1).

Marina, A. (2025). Resveratrol: Potential therapeutic effects on ocular health. Inflammopharmacology, Springer Nature. (Q1, IF 5.3, CiteScore 8.4).

Marina, A. (2025). Effectiveness of acarbose plus metformin and acarbose plus myo-inositol dual combination therapy in alleviating the metabolic and endocrinological complications of PCOS. European Journal of Obstetrics & Gynecology and Reproductive Medicine, Elsevier. (Q2, IF 2.1, CiteScore 4.6).

Marina, A. (2025). Therapeutic potential of acarbose in ameliorating the metabolic and endocrinological complications of polycystic ovarian syndrome: A review. Current Medical Research & Opinion, Taylor & Francis. (Q1, IF 2.3, CiteScore 4.2).

Marina, A. (2025). Clinical implications of acarbose plus myo-inositol therapy on the thyroid profile of women with PCOS. Journal of Pharmacy and Pharmacognosy Research, (Q2, IF 1.2, CiteScore 3.0).